Home
Akums Drugs & Pharmaceuticals Ltd Board of Directors
Board of Directors at Akums Drugs & Pharmaceuticals Ltd
Company Sec. & Compli. Officer
Independent Director
Independent Director
Independent Director
Managing Director
Key Highlights
- SANDEEP JAIN continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- SANJEEV JAIN continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Matangi Gowrishankar joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Dharamvir Malik joins the board as Company Sec. & Compli. Officer, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kewal Kundanlal Handa joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Akums Drugs & Pharmaceuticals Ltd
NSE: AKUMS
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 496.45 |
20 Feb 2025 | 511.75 |
19 Feb 2025 | 494.7 |
18 Feb 2025 | 501.8 |
17 Feb 2025 | 516.1 |
14 Feb 2025 | 524.3 |
13 Feb 2025 | 550.15 |
12 Feb 2025 | 549.55 |
11 Feb 2025 | 541.4 |
10 Feb 2025 | 571.25 |
Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd
Market Cap
7,813 Cr
EPS
9.1
P/E Ratio (TTM)
54.7
P/B Ratio (TTM)
2.8
Day’s High
515.9
Day’s Low
495.0
DTE
0.2
ROE
9.8
52 Week High
1174.85
52 Week Low
483.0
ROCE
7.5
Market Price of Akums Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Akums Drugs & Pharmaceuticals Ltd News Hub
Akums Drugs and Pharmaceuticals rises on debut
The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has
Read more
06 Aug 24
Akums Drugs and Pharmaceuticals IPO ends with strong subscription
The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha
Read more
02 Aug 24
Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times
The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha
Read more
01 Aug 24
Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter
Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202
Read more
26 Aug 24